SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) announced today that new data published online in The Lancet Oncology suggest that the company’s Immunoscore Immune ...

DURHAM, N.C. – The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, ...

Please provide your email address to receive an email when new articles are posted on . Tumor treating fields are electric fields designed to exert physical force to kill cancer cells. The addition of ...

FORT WORTH, Texas--(BUSINESS WIRE)--NanOlogy LLC, a clinical-stage interventional oncology drug company, announced today a single-site analysis of data from an ongoing Phase 2a clinical trial ...

Regarding the Unified QR Code, “JPQR” Promotion Project, eight new services have been added from today as payment services that can be applied from the online application form (PLUG). The Ministry of ...